Geneos Wealth Management’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-179
Closed -$4.84K – 2571
2024
Q2
$4.84K Sell
179
-112
-38% -$2.97K ﹤0.01% 1729
2024
Q1
$7.76K Hold
291
– – ﹤0.01% 1603
2023
Q4
$7.33K Sell
291
-23,324
-99% -$558K ﹤0.01% 1629
2023
Q3
$550K Sell
23,615
-6,179
-21% -$152K 0.03% 450
2023
Q2
$741K Sell
29,794
-1,523
-5% -$38.6K 0.04% 375
2023
Q1
$813K Sell
31,317
-3,085
-9% -$79.7K 0.05% 337
2022
Q4
$881K Sell
34,402
-3,496
-9% -$89.7K 0.05% 297
2022
Q3
$962K Buy
37,898
+1,548
+4% +$41.1K 0.07% 260
2022
Q2
$962K Sell
36,350
-215
-0.6% -$5.79K 0.05% 332
2022
Q1
$1.02M Buy
+36,565
New +$1.03M 0.04% 347
2021
Q2
– Sell
-13,950
Closed -$409K – 2908
2021
Q1
$409K Sell
13,950
-3,836
-22% -$113K 0.01% 685
2020
Q4
$34K Buy
+17,786
New +$536K ﹤0.01% 1641

Other funds holding DRSK

Geneos Wealth Management's DRSK Position: Q3 2024 in Review

Geneos Wealth Management sold out of Aptus Defined Risk ETF (DRSK) in Q3 2024, closing a stake of 179 shares — an estimated $4.84K sold.

Geneos Wealth Management first reported a position in DRSK in Q4 2020 and held it in 12 quarters. The position peaked at $1.02M in Q1 2022. 67 funds tracked by Wall St. Rank hold DRSK as of Q3 2024.

  • Geneos Wealth Management reported no remaining Aptus Defined Risk ETF position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 179 Aptus Defined Risk ETF shares in Q3 2024, an estimated $4.84K.
  • Geneos Wealth Management first reported a position in Aptus Defined Risk ETF in Q4 2020 and held it in 12 quarters.
  • Geneos Wealth Management's Aptus Defined Risk ETF position peaked at $1.02M in Q1 2022.
  • 67 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.